The Pennant Group, Inc. (NASDAQ:PNTG) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of The Pennant Group, Inc. (NASDAQ:PNTG) have earned a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $34.40.

Several research firms recently commented on PNTG. Wells Fargo & Company cut their price target on The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Truist Financial lowered their price target on The Pennant Group from $32.00 to $28.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Stephens restated an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research report on Thursday, September 4th. Finally, Wall Street Zen lowered The Pennant Group from a “buy” rating to a “hold” rating in a report on Friday, September 26th.

The Pennant Group Price Performance

Shares of The Pennant Group stock opened at $25.57 on Friday. The business has a 50 day simple moving average of $24.47 and a two-hundred day simple moving average of $25.85. The Pennant Group has a 12 month low of $21.18 and a 12 month high of $36.20. The stock has a market capitalization of $883.70 million, a P/E ratio of 32.78, a PEG ratio of 2.09 and a beta of 1.35. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.21 and a quick ratio of 1.21.

Institutional Trading of The Pennant Group

Hedge funds and other institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC increased its position in The Pennant Group by 56.9% in the 1st quarter. SG Americas Securities LLC now owns 23,413 shares of the company’s stock valued at $589,000 after acquiring an additional 8,490 shares during the period. GAMMA Investing LLC lifted its stake in The Pennant Group by 7,124.5% in the 1st quarter. GAMMA Investing LLC now owns 7,947 shares of the company’s stock valued at $200,000 after buying an additional 7,837 shares in the last quarter. Cubist Systematic Strategies LLC lifted its stake in The Pennant Group by 205.9% in the 1st quarter. Cubist Systematic Strategies LLC now owns 97,527 shares of the company’s stock valued at $2,453,000 after buying an additional 65,640 shares in the last quarter. Rhumbline Advisers raised its holdings in The Pennant Group by 8.6% in the 1st quarter. Rhumbline Advisers now owns 47,423 shares of the company’s stock valued at $1,193,000 after acquiring an additional 3,750 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in The Pennant Group by 22.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 77,885 shares of the company’s stock valued at $2,066,000 after acquiring an additional 14,020 shares during the last quarter. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.